The FGFR RGQ RT-PCR kit (Qiagen) is FDA-approved for detecting FGFR2/FGFR3 fusion variants in urothelial carcinoma (FGFR2-BICC1, FGFR2-CASP7, FGFR3-TACC3, FGFR3-BAIAP2L1). The gene discussed is FGFR2; the disease is urothelial carcinoma.